Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 17, 2013
Issued Date -
N/A
app pub date -
Jun 28, 2010
filing date -
Apr 15, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully